Voelkel NF - Search Results

1

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.

Voelkel NF, Tuder RM, Bridges J, Arend WP. Voelkel NF, et al. Am J Respir Cell Mol Biol. 1994 Dec;11(6):664-75. doi: 10.1165/ajrcmb.11.6.7946395. Am J Respir Cell Mol Biol. 1994. PMID: 7946395

2

A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.

Taraseviciene-Stewart L, Gera L, Hirth P, Voelkel NF, Tuder RM, Stewart JM. Taraseviciene-Stewart L, et al. Among authors: voelkel nf. Can J Physiol Pharmacol. 2002 Apr;80(4):269-74. doi: 10.1139/y02-047. Can J Physiol Pharmacol. 2002. PMID: 12025960

3

Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.

Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Le Cras TD, et al. Among authors: voelkel nf. Am J Physiol Lung Cell Mol Physiol. 2002 Sep;283(3):L555-62. doi: 10.1152/ajplung.00408.2001. Am J Physiol Lung Cell Mol Physiol. 2002. PMID: 12169575 Free article.

4

Oxidative stress in severe pulmonary hypertension.

Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF. Bowers R, et al. Among authors: voelkel nf. Am J Respir Crit Care Med. 2004 Mar 15;169(6):764-9. doi: 10.1164/rccm.200301-147OC. Epub 2003 Dec 30. Am J Respir Crit Care Med. 2004. PMID: 14701708

5

Emphysema lung tissue gene expression profiling.

Golpon HA, Coldren CD, Zamora MR, Cosgrove GP, Moore MD, Tuder RM, Geraci MW, Voelkel NF. Golpon HA, et al. Among authors: voelkel nf. Am J Respir Cell Mol Biol. 2004 Dec;31(6):595-600. doi: 10.1165/rcmb.2004-0008OC. Epub 2004 Jul 29. Am J Respir Cell Mol Biol. 2004. PMID: 15284076

6

Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.

Voelkel NF, Tuder R. Voelkel NF, et al. Ann N Y Acad Sci. 1994 May 28;725:104-9. doi: 10.1111/j.1749-6632.1994.tb39794.x. Ann N Y Acad Sci. 1994. PMID: 8030981 No abstract available.

7

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Voelkel NF, Tuder RM, Wade K, Höper M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F. Voelkel NF, et al. J Clin Invest. 1996 Jun 1;97(11):2491-8. doi: 10.1172/JCI118696. J Clin Invest. 1996. PMID: 8647941 Free PMC article.

8

Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.

Voelkel NF, Tuder RM. Voelkel NF, et al. Eur Respir J. 1995 Dec;8(12):2129-38. doi: 10.1183/09031936.95.08122129. Eur Respir J. 1995. PMID: 8666110 Free article. Review.

9

Vascular endothelial growth factor in pulmonary hypertension.

Voelkel NF, Hoeper M, Maloney J, Tuder RM. Voelkel NF, et al. Ann N Y Acad Sci. 1996 Oct 31;796:186-93. doi: 10.1111/j.1749-6632.1996.tb32580.x. Ann N Y Acad Sci. 1996. PMID: 8906225

10

Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

Höper MM, Voelkel NF, Bates TO, Allard JD, Horan M, Shepherd D, Tuder RM. Höper MM, et al. Among authors: voelkel nf. Am J Respir Cell Mol Biol. 1997 Dec;17(6):748-56. doi: 10.1165/ajrcmb.17.6.2888. Am J Respir Cell Mol Biol. 1997. PMID: 9409562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters